GSK Derm Division Takes Over Lifecycle Expansion For Allergan Acne Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Allergan's acne cream Tazorac may be reborn as a foam now that GlaxoSmithKline has filed an NDA for it.